Compare AVD & HYFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVD | HYFT |
|---|---|---|
| Founded | 1969 | 1983 |
| Country | United States | United States |
| Employees | N/A | 102 |
| Industry | Agricultural Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.8M | 57.9M |
| IPO Year | 1995 | N/A |
| Metric | AVD | HYFT |
|---|---|---|
| Price | $3.14 | $1.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $12.00 | $5.00 |
| AVG Volume (30 Days) | ★ 241.0K | 161.4K |
| Earning Date | 03-16-2026 | 03-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $515,114,000.00 | N/A |
| Revenue This Year | $8.82 | N/A |
| Revenue Next Year | N/A | $29.18 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.05 | $0.99 |
| 52 Week High | $5.92 | $3.00 |
| Indicator | AVD | HYFT |
|---|---|---|
| Relative Strength Index (RSI) | 57.24 | 57.22 |
| Support Level | $2.65 | $1.02 |
| Resistance Level | $5.47 | $1.48 |
| Average True Range (ATR) | 0.20 | 0.09 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 58.67 | 65.15 |
American Vanguard Corp is a United States-based diversified specialty and agricultural products company. The company is a manufacturer of specialty solutions that develops and markets safe synthetic, biological, and biorational products for agricultural, commercial, and consumer uses. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.